Related Experiment Video
Updated: Feb 23, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
[Pathogen distribution and bacterial resistance in children with severe community-acquired pneumonia]
Yun-Yun Lu1, Rong Luo, Zhou Fu
1Department of Respiratory Medicine, Children's Hospital of Chongqing Medical University, Chongqing 400014, China. luo_rong_512@aliyun.com.
Insights
Bacteria are the primary cause of severe community-acquired pneumonia (CAP) in children, with mixed infections being common. High rates of antibiotic resistance were observed in common bacterial pathogens.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Antimicrobial Resistance
Background:
- Severe community-acquired pneumonia (CAP) poses a significant health threat to children worldwide.
- Understanding the spectrum of pathogens and their antimicrobial susceptibility is crucial for effective treatment.
Purpose of the Study:
- To determine the distribution of various pathogens causing severe CAP in hospitalized children.
- To investigate the prevalence of bacterial resistance patterns in these pediatric CAP cases.
Main Methods:
- A cohort of 522 children hospitalized with severe CAP in 2016 was analyzed.
- Bacterial identification and antimicrobial susceptibility testing were performed using the phoenix-100 system.
- Respiratory viruses, Mycoplasma pneumoniae (MP), and Chlamydia trachomatis (CT) were detected via direct immunofluorescence assay and quantitative real-time PCR.
Main Results:
- Pathogens were identified in 80.3% of children, with mixed infections occurring in 45.3%.
- Bacteria constituted the majority of identified pathogens (54.5%), followed by viruses (38.0%).
- High drug-resistance rates were noted for Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Escherichia coli, and Klebsiella pneumoniae against common antibiotics, though sensitivity to specific agents was observed.
Conclusions:
- Bacteria are the predominant pathogens in severe pediatric CAP, and mixed infections are frequent.
- Significant antimicrobial resistance among key bacterial pathogens necessitates careful antibiotic selection for treating severe CAP in children.
Objective:
To investigate the distribution of pathogens and bacterial resistance in children with severe community-acquired pneumonia (CAP).
Methods:
A total of 522 children with severe CAP who were hospitalized in 2016 were enrolled as study subjects. According to their age, they were divided into infant group (402 infants aged 28 days to 1 year), young children group (73 children aged 1 to 3 years), preschool children group (35 children aged 3 to 6 years), and school-aged children group (12 children aged ≥6 years). According to the onset season, all children were divided into spring group (March to May, 120 children), summer group (June to August, 93 children), autumn group (September to November, 105 children), and winter group (December to February, 204 children). Sputum specimens from the deep airway were collected from all patients. The phoenix-100 automatic bacterial identification system was used for bacterial identification and drug sensitivity test. The direct immunofluorescence assay was used to detect seven common respiratory viruses. The quantitative real-time PCR was used to detect Mycoplasma pneumoniae (MP) and Chlamydia trachomatis (CT).
Results:
Of all the 522 children with severe CAP, 419 (80.3%) were found to have pathogens, among whom 190 (45.3%) had mixed infection. A total of 681 strains of pathogens were identified, including 371 bacterial strains (54.5%), 259 viral strains (38.0%), 12 fungal strains (1.8%), 15 MP strains (2.2%), and 24 CT strains (3.5%). There were significant differences in the distribution of bacterial, viral, MP, and fungal infections between different age groups (P<0.05). There were significant differences in the incidence rate of viral infection between different season groups (P<0.05), with the highest incidence rate in winter. The drug-resistance rates of Streptococcus pneumoniae to erythromycin, tetracycline, and clindamycin reached above 85%, and the drug-resistance rates of Staphylococcus aureus to penicillin, erythromycin, and clindamycin were above 50%; they were all sensitive to vancomycin and linezolid. The drug-resistance rates of Haemophilus influenzae to cefaclor and cefuroxime were above 60%, but it was sensitive to cefotaxime. The drug-resistance rates of Escherichia coli and Klebsiella pneumoniae to ampicillin, cefotaxime, and ceftriaxone were above 60%, but they were sensitive to carbapenems and compound preparation of enzyme inhibitors.
Conclusions:
Bacteria are the main pathogens in children with severe CAP and mixed infection is prevalent. The drug-resistance rates of these pathogenic bacteria are high.
More Related Videos
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Development of Antibiotic Resistance
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology